Can pelvic floor muscle strength impact female sexual function? Retrospective cross-sectional multicentric study

Alvear C1, Pasqualotto L1, Biella A2, Marques J2, Pereira L2, Alves F2, Lunardi A2, Adami D3, Nagib A4, Martinho N5, Piccini A1, Sathler T6, Silva V2, Michelutti L1, Volpato M1, Riccetto C2, Botelho S1

Research Type

Clinical

Abstract Category

Rehabilitation

Abstract 517
On Demand Rehabilitation
Scientific Open Discussion Session 34
On-Demand
Sexual Dysfunction Rehabilitation Pelvic Floor
1. Federal University of Alfenas - Motor Science Institute - Postgraduate Program in Rehabilitation Sciences - Alfenas, Minas Gerais - Brazil., 2. State University of Campinas - School of Medical Sciences - Postgraduate Program in Surgical Science, Campinas, São Paulo, Brazil, 3. Pontifical Catholic University of Minas Gerais - PUC Minas, Poços de Caldas, Minas Gerais, Brazil, 4. University Center of the Associated Teaching Faculties - UNIFAE, São João da Boa Vista, São Paulo, Brazil, 5. Regional University Center of Espirito Santo do Pinhal - UNIPINHAL, Espirito Santo do Pinhal, São Paulo, Brazil, 6. College Madre Thais - FMT, Ilhéus, Bahia, Brazil
Presenter
C

Constanza Alvear

Links

Abstract

Hypothesis / aims of study
The female pelvic floor muscles (PFM) play an important role in sexual function. We hypothesized that PFM strength can play an important role in some aspects of female sexual function like orgarsm, motivating us to further investigate PFM strength in women with (with_SD) and without sexual dysfunction (without_SD).
Study design, materials and methods
Retrospective multicentric cross-sectional study including women with and without sexual dysfunction (Female Sexual Function Index - FSFI cutoff point <26.55), over 18 years old, analyzed by age range, considering demographic, clinical, anthropometric and PFM strength (Modified Oxford Scale - MOS) data. The statistical analysis was performed from the data obtained in the following statistical tests: Chi-square and Mann-Whitney. Linear regression analysis was used for the study of clinical, demographic and anthropometric data, in relation to the FSFI total score, as well as the relation between age, muscle strength and the FSFI domains The data were transformed in ranks and the level of significance adopted for this study was 5% (SAS.9.4).
Results
Out of 1013 medical records, 982 women with an average age of 45.76 (±15.25) were included in the study. Of these, 679 (69.14%) presented FSFI score <26.55, while 303 (30.86%) presented FSFI ≥26.55. Table 1 presents the relation between age range and PFM strength (MOS) analyzed by univariate linear regression, considering the FSFI domains.The analysis identified that women over the age of 46 have a lower score in relation to all domains of the FSFI and that those with MOS: 4-5 have better sexual function, especially in the domains of desire, arousal, lubrication and orgasm. Higher scores in the satisfaction and pain domains were observed in women with MOS between 3 and 5. 
The FSFI total score was related to demographic and anthropometric characteristics analyzed by univariate and multivariate linear regression (Table 2).Univariate linear regression showed that single women, with higher education, body mass index <25 kg / m² and lower parity had higher scores on the FSFI. In multivariate linear regression white women, <45 years old, family income >4 minimum wages and regular physical activity practitioners also showed better sexual function.
Interpretation of results
Our study identified the relation between sexual function and muscle strength in women of different ages. We observed that women without_SD, identified by FSFI total score ≥26.55, presented higher PFM strength in relation to women with_SD. Similarly, women with higher PFM strength presented lower scores in all FSFI domains.
Concluding message
Based on our results we can conclude that demographic, clinical and anthropometric conditions can influence both PFM strength and female sexual function. Our findings demonstrate that women with higher PFM strength presented less complaints of sexual dysfunction.
Figure 1
Figure 2
Disclosures
Funding This work was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance Code 001 and the Fundação de Amparo à Pesquisa do Estado de Minas Gerais - FAPEMIG (PPM-00471-18), through the Postgraduate Program in Rehabilitation Science of the Federal University of Alfenas - UNIFAL/MG. Clinical Trial No Subjects Human Ethics Committee The present study was approved by the Research Ethics Committee (CEP) from the Campinas State University, in accordance with resolution n.466/12 of the National Health Council (CNS), with CAAE number: 36158920.2.1001.5404 and opinion number: 4.343.687. Helsinki Yes Informed Consent Yes
02/05/2024 19:23:40